Zaima Mazorra Herrera

Summary

Affiliation: Center of Molecular Immunology
Country: Cuba

Publications

  1. ncbi request reprint Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients
    Zaima Mazorra Herrera
    Clinical Immunology Department at Clinical Direction, Center of Molecular Immunology, Street 216 Corner 15, PO Box 16040, Havana, Cuba
    Cancer Immunol Immunother 63:737-47. 2014
  2. pmc Immunosenescence and gender: a study in healthy Cubans
    Beatriz García Verdecia
    Department of Clinical Immunology, Center of Molecular Immunology, P, O, Box 16040, 216 St, Havana, Cuba
    Immun Ageing 10:16. 2013
  3. doi request reprint Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge
    Zaima Mazorra
    Department of Vaccines, Center of Molecular Immunology, Havana, Cuba
    Cancer Immunol Immunother 57:1771-80. 2008

Collaborators

  • Circe Mesa
  • Zaima Mazorra Herrera
  • Tania Crombet Ramos
  • Beatriz García Verdecia
  • Zaima Mazorra
  • Patricia Lorenzo-Luaces
  • Agustín Lage Dávila
  • Danay Saavedra Hernández
  • Teresita de Jesús Badía Alvarez
  • Idrissa Leonard Rupalé
  • Audry Fernandez
  • Luis E Fernandez

Detail Information

Publications3

  1. ncbi request reprint Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients
    Zaima Mazorra Herrera
    Clinical Immunology Department at Clinical Direction, Center of Molecular Immunology, Street 216 Corner 15, PO Box 16040, Havana, Cuba
    Cancer Immunol Immunother 63:737-47. 2014
    ..We also discuss preliminary findings obtained in a trial of combination of these two vaccines and future challenges with these therapies. ..
  2. pmc Immunosenescence and gender: a study in healthy Cubans
    Beatriz García Verdecia
    Department of Clinical Immunology, Center of Molecular Immunology, P, O, Box 16040, 216 St, Havana, Cuba
    Immun Ageing 10:16. 2013
    ..The aim of this study was to determine the effect of ageing on lymphocytes in a population with a high prevalence of CMV infection in all ages, and to compare gender differences related to the immunosenescence markers...
  3. doi request reprint Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge
    Zaima Mazorra
    Department of Vaccines, Center of Molecular Immunology, Havana, Cuba
    Cancer Immunol Immunother 57:1771-80. 2008
    ..Paradoxically, in spite of the glycolipidic nature of this antigen, these findings demonstrate the direct involvement of the cellular immune response in the anti-tumour protection induced by a ganglioside-based vaccine...